Phrixus Pharmaceuticals

Phrixus Pharmaceuticals

Phrixus Pharmaceuticals

Phrixus Pharmaceuticals is developing Carmeseal™ (poloxamer 188 or P188) for Duchenne muscular dystrophy and acute decompensated heart failure.
Founded
2006
Follow us
Alexa global traffic share